Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Exenatide
AstraZeneca UK Ltd
A10BJ01
Exenatide
250microgram/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 06010203; GTIN: 5014602101299
User manual 1 PEN USER MANUAL BYETTA 10 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED PEN (EXENATIDE) Section 1. WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN READ THIS SECTION COMPLETELY BEFORE YOU BEGIN. THEN, MOVE ON TO SECTION 2 – GETTING STARTED. Read these instructions carefully BEFORE using your Byetta pen. Also read the Byetta Package leaflet that comes with the Byetta pen carton. You need to use the pen correctly in order to get the most benefit from Byetta. Failure to follow these instructions completely may result in a wrong dose, a broken pen or an infection. THESE INSTRUCTIONS DO NOT TAKE THE PLACE OF TALKING WITH YOUR HEALTHCARE PROFESSIONAL ABOUT YOUR MEDICAL CONDITION OR YOUR TREATMENT. IF YOU ARE HAVING PROBLEMS USING YOUR BYETTA PEN, CONTACT YOUR HEALTHCARE PROFESSIONAL. IMPORTANT INFORMATION ABOUT YOUR BYETTA PEN Byetta is injected twice a day, the pen contains enough medicine for 30 days. You do not have to measure any doses, the pen measures each dose for you. DO NOT TRANSFER THE MEDICINE IN THE BYETTA PEN TO A SYRINGE. If any part of your pen appears broken or damaged, do not use the pen. DO NOT SHARE YOUR PEN OR NEEDLES AS THIS MAY RISK TRANSMISSION OF INFECTIOUS AGENTS. This pen is not recommended for use by people who are blind or who cannot see well enough. Help will be needed by a person trained to use the pen. Healthcare professionals or other caregivers should follow local or institutional policies regarding needle handling. FOLLOW THE INSTRUCTIONS FOR HYGIENIC INJECTION TECHNIQUE RECOMMENDED BY YOUR HEALTHCARE PROFESSIONAL. Follow Section 2 only to set up a new pen before first use. Section 3 of this manual should be used for every injection. ABOUT INJECTION NEEDLES Your Byetta pen is suitable for use with Becton, Dickinson and Company pen injection needles. DO I USE A NEW NEEDLE FOR EACH INJECTION? Yes. Do not reuse needles. Remove the needle immediately after each injection. This will help prevent leakage of Byetta, keep out air bubbles Read the complete document
OBJECT 1 BYETTA 5 MICROGRAMS SOLUTION FOR INJECTION, PREFILLED PEN Summary of Product Characteristics Updated 04-Aug-2017 | AstraZeneca UK Limited 1. Name of the medicinal product Byetta 5 micrograms solution for injection in pre-filled pen Byetta 10 micrograms solution for injection in pre-filled pen 2. Qualitative and quantitative composition Each dose contains 5 micrograms (mcg) of exenatide in 20 microlitres (mcl), (0.25 mg exenatide per ml). Each dose contains 10 micrograms (mcg) of exenatide in 40 microlitres (mcl), (0.25 mg exenatide per ml). Excipient with known effect: Byetta 5 mcg: Each dose contains 44 mcg metacresol. Byetta 10 mcg: Each dose contains 88 mcg metacresol. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection (injection). Clear, colourless solution. 4. Clinical particulars 4.1 Therapeutic indications Byetta is indicated for treatment of type 2 diabetes mellitus in combination with: - metformin - sulphonylureas - thiazolidinediones - metformin and a sulphonylurea - metformin and a thiazolidinedione in adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies. Byetta is also indicated as adjunctive therapy to basal insulin with or without metformin and/or pioglitazone in adults who have not achieved adequate glycaemic control with these medicinal products. 4.2 Posology and method of administration Posology Immediate-release exenatide (Byetta) therapy should be initiated at 5 mcg exenatide per dose administered twice daily (BID) for at least one month in order to improve tolerability. The dose of exenatide can then be increased to 10 mcg BID to further improve glycaemic control. Doses higher than 10 mcg BID are not recommended. Immediate-release exenatide is available as either a 5 mcg or a 10 mcg exenatide per dose pre-filled pen. Immediate-release exenatide can be administered at any time within the 60-minute period before the morning and evening meal (or two main meals of the day, approximately 6 Read the complete document